Cabaletta Bio CABA
NASDAQ CABA
$1.98 -0.02 (-1.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cabaletta Bio (CABA) Capital Leases (2024 - 2026)

Updated

Cabaletta Bio's Capital Leases was $4.74 million in Q2 2026, up 21.5% from $3.9 million a year earlier.

Analysis

Cabaletta Bio (CABA) Capital Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Capital Leases at Cabaletta Bio came in at $2.88 million, down 11.2% from FY2024.

  • In earlier years, Capital Leases was $3.24 million in FY2024.
  • The Q2 2026 figure marks the highest quarterly Capital Leases since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Cabaletta Bio 339.09 Mn 339.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.74 Mn
Dec 31, 2025 2.88 Mn
Sep 30, 2025 4.56 Mn
Jun 30, 2025 3.90 Mn
Mar 31, 2025 8.11 Mn
Dec 31, 2024 3.24 Mn
API Access

Cabaletta Bio Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=CABA&period=max&api_key=YOUR_API_KEY